These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 37808752)

  • 1. CRISPR-Cas inhibits plasmid transfer and immunizes bacteria against antibiotic resistance acquisition in manure.
    Upreti C; Kumar P; Durso L; Palmer K
    bioRxiv; 2024 May; ():. PubMed ID: 37808752
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CRISPR-Cas inhibits plasmid transfer and immunizes bacteria against antibiotic resistance acquisition in manure.
    Upreti C; Kumar P; Durso LM; Palmer KL
    Appl Environ Microbiol; 2024 Sep; 90(9):e0087624. PubMed ID: 39158272
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CRISPR-Cas and Restriction-Modification Act Additively against Conjugative Antibiotic Resistance Plasmid Transfer in Enterococcus faecalis.
    Price VJ; Huo W; Sharifi A; Palmer KL
    mSphere; 2016; 1(3):. PubMed ID: 27303749
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Enterococcus faecalis Strains with Compromised CRISPR-Cas Defense Emerge under Antibiotic Selection for a CRISPR-Targeted Plasmid.
    Huo W; Price VJ; Sharifi A; Zhang MQ; Palmer KL
    Appl Environ Microbiol; 2023 Jun; 89(6):e0012423. PubMed ID: 37278656
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Enterococcus faecalis CRISPR-Cas Is a Robust Barrier to Conjugative Antibiotic Resistance Dissemination in the Murine Intestine.
    Price VJ; McBride SW; Hullahalli K; Chatterjee A; Duerkop BA; Palmer KL
    mSphere; 2019 Jul; 4(4):. PubMed ID: 31341074
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Conjugative Delivery of CRISPR-Cas9 for the Selective Depletion of Antibiotic-Resistant Enterococci.
    Rodrigues M; McBride SW; Hullahalli K; Palmer KL; Duerkop BA
    Antimicrob Agents Chemother; 2019 Nov; 63(11):. PubMed ID: 31527030
    [TBL] [Abstract][Full Text] [Related]  

  • 7. An Attenuated CRISPR-Cas System in Enterococcus faecalis Permits DNA Acquisition.
    Hullahalli K; Rodrigues M; Nguyen UT; Palmer K
    mBio; 2018 May; 9(3):. PubMed ID: 29717009
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Role of CRISPR-Cas system on antibiotic resistance patterns of Enterococcus faecalis.
    Gholizadeh P; Aghazadeh M; Ghotaslou R; Rezaee MA; Pirzadeh T; Cui L; Watanabe S; Feizi H; Kadkhoda H; Kafil HS
    Ann Clin Microbiol Antimicrob; 2021 Jul; 20(1):49. PubMed ID: 34321002
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Exploiting CRISPR-Cas to manipulate
    Hullahalli K; Rodrigues M; Palmer KL
    Elife; 2017 Jun; 6():. PubMed ID: 28644125
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prevalence of CRISPR-Cas Systems and Their Possible Association with Antibiotic Resistance in
    Alduhaidhawi AHM; AlHuchaimi SN; Al-Mayah TA; Al-Ouqaili MTS; Alkafaas SS; Muthupandian S; Saki M
    Infect Drug Resist; 2022; 15():1143-1154. PubMed ID: 35340673
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Role of CRISPR-Cas systems and anti-CRISPR proteins in bacterial antibiotic resistance.
    Kadkhoda H; Gholizadeh P; Samadi Kafil H; Ghotaslou R; Pirzadeh T; Ahangarzadeh Rezaee M; Nabizadeh E; Feizi H; Aghazadeh M
    Heliyon; 2024 Jul; 10(14):e34692. PubMed ID: 39149034
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Multidrug-resistant enterococci lack CRISPR-cas.
    Palmer KL; Gilmore MS
    mBio; 2010 Oct; 1(4):. PubMed ID: 21060735
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Resensitizing tigecycline- and colistin-resistant
    Zhang H; Chen B; Wang Z; Peng K; Liu Y; Wang Z
    Microbiol Spectr; 2024 Apr; 12(4):e0388423. PubMed ID: 38385691
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Association of CRISPR-Cas System with the Antibiotic Resistance and Virulence Genes in Nosocomial Isolates of
    Tao S; Chen H; Li N; Fang Y; Xu Y; Liang W
    Infect Drug Resist; 2022; 15():6939-6949. PubMed ID: 36474907
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CRISPR-Cas-Based Antimicrobials: Design, Challenges, and Bacterial Mechanisms of Resistance.
    Mayorga-Ramos A; Zúñiga-Miranda J; Carrera-Pacheco SE; Barba-Ostria C; Guamán LP
    ACS Infect Dis; 2023 Jul; 9(7):1283-1302. PubMed ID: 37347230
    [TBL] [Abstract][Full Text] [Related]  

  • 16. On-Farm Anaerobic Digestion of Dairy Manure Reduces the Abundance of Antibiotic Resistance-Associated Gene Targets and the Potential for Plasmid Transfer.
    Tran TT; Scott A; Tien YC; Murray R; Boerlin P; Pearl DL; Liu K; Robertson J; Nash JHE; Topp E
    Appl Environ Microbiol; 2021 Jun; 87(14):e0298020. PubMed ID: 33931422
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Conjugation Assay for Testing CRISPR-Cas Anti-plasmid Immunity in Staphylococci.
    Walker FC; Hatoum-Aslan A
    Bio Protoc; 2017 May; 7(9):. PubMed ID: 28752109
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Exploring the Interplay of the CRISPR-CAS System with Antibiotic Resistance in
    Shabbir MAB; Ul-Rahman A; Iftikhar MR; Rasheed M; Maan MK; Sattar A; Ahmad M; Khan FA; Ahmad W; Riaz MI; Aslam HB
    Medicina (Kaunas); 2024 Jan; 60(1):. PubMed ID: 38256391
    [No Abstract]   [Full Text] [Related]  

  • 19. CRISPR-Cas System: A New Dawn to Combat Antibiotic Resistance.
    Rafiq MS; Shabbir MA; Raza A; Irshad S; Asghar A; Maan MK; Gondal MA; Hao H
    BioDrugs; 2024 May; 38(3):387-404. PubMed ID: 38605260
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Innovative Delivery System Combining CRISPR-Cas12f for Combatting Antimicrobial Resistance in Gram-Negative Bacteria.
    Long TF; Zhou SY; Huang ZL; Li G; Zhong Q; Zhang XJ; Li YY; Chen CP; Xia LJ; Wei R; Wan L; Gao A; Ren H; Liao XP; Liu YH; Chen L; Sun J
    ACS Synth Biol; 2024 Jun; 13(6):1831-1841. PubMed ID: 38863339
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.